70%-80% Drop In Participation For Phase 3 Trials Of Covaxin: Official

Despite phase-1 trial of its Covaxin vaccine seeing "encouraging" results, Hyderabad-based Bharat Biotech is facing challenges in phase 3 trials of its vaccine in India, a top official associated with...